Sphaera Revenue and Competitors
Estimated Revenue & Valuation
- Sphaera's estimated annual revenue is currently $2.5M per year.
- Sphaera's estimated revenue per employee is $101,500
Employee Data
- Sphaera has 25 Employees.
- Sphaera grew their employee count by -17% last year.
Sphaera's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | EVP | Reveal Email/Phone |
4 | Director Infrastructure Services | Reveal Email/Phone |
5 | Datacenter Operations Field Manager | Reveal Email/Phone |
6 | Senior Technical Project Manager | Reveal Email/Phone |
7 | Telecommunications equipment installer | Reveal Email/Phone |
8 | Administrative Coordinator | Reveal Email/Phone |
Sphaera Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.1M | 27 | -4% | N/A | N/A |
What Is Sphaera?
Sphaera provides full lifecycle IT asset management services for Fortune 2000 customers. We are the one-stop shop you leverage so you can focus on your core business. Build, Run, Migrate & Decom services providing peace of mind.
keywords:N/A
N/A
Total Funding
25
Number of Employees
$2.5M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sphaera News
... enorme crecimiento por parte de industrias de alto rango | GlaxoSmithKline Plc, Sphaera Pharma Pvt. Ltd., Sumitomo Dainippon Pharma Co.
... Lohocla Research Corporation; Mertiva AB; Novaremed; Pharmaleads; RAPID Pharmaceuticals AG; Relmada Therapeutics, Inc. Sphaera Pharma Pvt. Ltd.
... Relmada Therapeutics, Sphaera Pharma Pvt. Ltd., Theravasc, Inc. This comprehensive Diabetic Neuropathic Pain Drug Market report helps in determining the...
Other Companies in Beaverton
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2M | 25 | -22% | N/A |
#2 | $4M | 25 | -4% | N/A |
#3 | $3M | 25 | -4% | N/A |
#4 | $4M | 25 | 4% | N/A |
#5 | $5.9M | 26 | -7% | N/A |